| Dr Bret J Barrett, MD | |
|
1200 N State St, Suite 500, Jackson, MS 39202-2000 | |
| (601) 352-2273 | |
| (601) 714-3415 |
| Full Name | Dr Bret J Barrett |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 22 Years |
| Location | 1200 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265640577 | NPI | - | NPPES |
| 06903314 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 20210 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mississippi Baptist Medical Center | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Foundation Of Central Mississippi Inc | 1153216411 | 233 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.
Revolutions Medical signs Letter of Intent today with Medical Investment Group, LLC (MIG) for the Manufacturing of the RevVac Safety Syringe. The final terms are expected to be completed in definitive documents between the parties no later than September 17th, 2010.
Novation, the leading health care supply contracting company, announced today the addition of St. Jude Medical (St. Paul, MN) to its portfolio of agreements for Cardiac Rhythm Management products.
The U.S. Food and Drug Administration today completed a coordinated, weeklong, international effort, called the International Internet Week of Action (IIWA), intended to curb illegal actions involving medical products.
› Verified 6 days ago
| Entity Name | Medical Foundation Of Central Mississippi Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992774814 PECOS PAC ID: 1153216411 Enrollment ID: O20040217000380 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.
Revolutions Medical signs Letter of Intent today with Medical Investment Group, LLC (MIG) for the Manufacturing of the RevVac Safety Syringe. The final terms are expected to be completed in definitive documents between the parties no later than September 17th, 2010.
Novation, the leading health care supply contracting company, announced today the addition of St. Jude Medical (St. Paul, MN) to its portfolio of agreements for Cardiac Rhythm Management products.
The U.S. Food and Drug Administration today completed a coordinated, weeklong, international effort, called the International Internet Week of Action (IIWA), intended to curb illegal actions involving medical products.
› Verified 6 days ago
| Entity Name | Mississippi Baptist Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467589556 PECOS PAC ID: 9234026600 Enrollment ID: O20110707000181 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.
Revolutions Medical signs Letter of Intent today with Medical Investment Group, LLC (MIG) for the Manufacturing of the RevVac Safety Syringe. The final terms are expected to be completed in definitive documents between the parties no later than September 17th, 2010.
Novation, the leading health care supply contracting company, announced today the addition of St. Jude Medical (St. Paul, MN) to its portfolio of agreements for Cardiac Rhythm Management products.
The U.S. Food and Drug Administration today completed a coordinated, weeklong, international effort, called the International Internet Week of Action (IIWA), intended to curb illegal actions involving medical products.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bret J Barrett, MD 965 Ridge Lake Blvd, Ste 103, Memphis, TN 38120-9446 Ph: (901) 227-3255 | Dr Bret J Barrett, MD 1200 N State St, Suite 500, Jackson, MS 39202-2000 Ph: (601) 352-2273 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.
Revolutions Medical signs Letter of Intent today with Medical Investment Group, LLC (MIG) for the Manufacturing of the RevVac Safety Syringe. The final terms are expected to be completed in definitive documents between the parties no later than September 17th, 2010.
Novation, the leading health care supply contracting company, announced today the addition of St. Jude Medical (St. Paul, MN) to its portfolio of agreements for Cardiac Rhythm Management products.
The U.S. Food and Drug Administration today completed a coordinated, weeklong, international effort, called the International Internet Week of Action (IIWA), intended to curb illegal actions involving medical products.
› Verified 6 days ago
Graves Crawley Stubblefield Jr., M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 406 Briarwood Dr, Jackson, MS 39206 Phone: 601-991-1933 Fax: 601-978-3844 | |
Dr. Rebecca Chick Pace, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 N State St, Suite 500, Jackson, MS 39202 Phone: 601-352-2273 Fax: 601-714-3415 | |
Jewelian Akbar Baig, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 971 Lakeland Dr Ste 356, Jackson, MS 39216 Phone: 601-200-4644 Fax: 601-200-4645 | |
Jo P Deal, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 766 Lakeland Dr, A, Jackson, MS 39216 Phone: 601-368-3440 Fax: 601-368-3441 | |
Caryl P. Sumrall, FNP Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2500 North State Street, Department Of Medicine/division Of General Internal Med, Jackson, MS 39216 Phone: 601-984-5660 | |
Meghan Alford Luter, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5532 | |
Tammy H Young, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1227 N State St, Ste 101, Jackson, MS 39202 Phone: 601-355-2485 Fax: 601-353-1463 |